Kathleen Ford

CIK: 0001785406

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)9 (69.2%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (30.8%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

KURA

Kura Oncology, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (13 total)

KURA
Kura Oncology, Inc.
Sep 29, 2026
Sale(S)
Direct
3.7K shares at avg. $10.75$39K
KURA
Kura Oncology, Inc.
Sep 28, 2026
Sale(S)
Direct
6.9K shares at avg. $10.50$72K
KURA
Kura Oncology, Inc.
May 19, 2026
Sale(S)
Direct
2.3K shares at avg. $9.08$20K
KURA
Kura Oncology, Inc.
Jan 27, 2026
Sale(S)
Direct
1.8K shares at avg. $8.46$15K
KURA
Kura Oncology, Inc.
Jan 2, 2026
Award(A)
Direct
50K shares-
KURA
Kura Oncology, Inc.
Nov 14, 2025
Sale(S)
Direct
6.9K shares at avg. $11.18$77K
KURA
Kura Oncology, Inc.
Nov 13, 2025
Award(A)
Direct
48.9K shares-
KURA
Kura Oncology, Inc.
Sep 29, 2025
Sale(S)
Direct
6.9K shares at avg. $8.94$62K
KURA
Kura Oncology, Inc.
Sep 27, 2025
Award(A)
Direct
48.9K shares-
KURA
Kura Oncology, Inc.
May 19, 2025
Sale(S)
Direct
1.6K shares at avg. $6.28$10K
KURA
Kura Oncology, Inc.
Jan 28, 2025
Sale(S)
Direct
1.8K shares at avg. $7.87$14K
KURA
Kura Oncology, Inc.
Jan 2, 2025
Award(A)
Option to purchase common stock
Direct
185K shares-
KURA
Kura Oncology, Inc.
Nov 18, 2024
Sale(S)
Direct
526 shares at avg. $16.03$8K

		Type	Shares	Price		Ownership
Sep 29, 2026	KURA Kura Oncology, Inc.	Sale(S)	3,668	$10.75	$39,437	Direct
Sep 28, 2026	KURA Kura Oncology, Inc.	Sale(S)	6,906	$10.50	$72,494	Direct
May 19, 2026	KURA Kura Oncology, Inc.	Sale(S)	2,257	$9.08	$20,483	Direct
Jan 27, 2026	KURA Kura Oncology, Inc.	Sale(S)	1,813	$8.46	$15,339	Direct
Jan 2, 2026	KURA Kura Oncology, Inc.	Award(A)	50,000	-	$0	Direct
Nov 14, 2025	KURA Kura Oncology, Inc.	Sale(S)	6,902	$11.18	$77,143	Direct
Nov 13, 2025	KURA Kura Oncology, Inc.	Award(A)	48,900	-	-	Direct
Sep 29, 2025	KURA Kura Oncology, Inc.	Sale(S)	6,892	$8.94	$61,630	Direct
Sep 27, 2025	KURA Kura Oncology, Inc.	Award(A)	48,900	-	-	Direct
May 19, 2025	KURA Kura Oncology, Inc.	Sale(S)	1,558	$6.28	$9,777	Direct
Jan 28, 2025	KURA Kura Oncology, Inc.	Sale(S)	1,817	$7.87	$14,303	Direct
Jan 2, 2025	KURA Kura Oncology, Inc.	Award(A) Option to purchase common stock	185,000	-	-	Direct
Nov 18, 2024	KURA Kura Oncology, Inc.	Sale(S)	526	$16.03	$8,434	Direct

1-13 of 13 transactions

About FORD KATHLEEN

FORD KATHLEEN (SEC CIK 0001785406) files insider reports with the SEC as Chief Operating Officer of Kura Oncology, Inc. (KURA).

Signal8 holds 10 ownership filings by FORD KATHLEEN, all Form 4s, filed between Nov 19, 2024 and Sep 29, 2026. Those filings report 13 transactions, from Nov 18, 2024 to Sep 29, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on FORD KATHLEEN's filings is in SAN DIEGO, CA.

Recent filings by FORD KATHLEEN

Sep 29, 2026: Open-market sale of KURA shares (Form 4, code S).
Sep 28, 2026: Open-market sale of KURA shares (Form 4, code S).
May 19, 2026: Open-market sale of KURA shares (Form 4, code S).
Jan 27, 2026: Open-market sale of KURA shares (Form 4, code S).
Jan 2, 2026: Grant or award of KURA shares (Form 4, code A).

Other insiders filing for Kura Oncology, Inc. (KURA)

Bair Teresa Brophy, Chief Legal Officer
Leoni Mollie, Chief Medical Officer
DOYLE THOMAS JAMES, SVP, Finance & Accounting
Powl Brian T., Chief Commercial Officer
Burrows Francis, Chief Scientific Officer
Fulk Jennifer, Chief Financial Officer

How to read Form 4 transaction codes